← All indications
Disease
A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
Subtype terms (1)
More specific conditions that are subtypes of Disease in the MeSH hierarchy.
- Syndrome
7 drugs (6 approved, 1 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (7)
Phase 2 trials (3)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (279)
- Skyland Behavioral Health Associates
- University of Southern Denmark
- Shandong Mental Health Center
- University of Pisa
- The University of Hong Kong
- Erzurum Regional Training & Research Hospital
- Roche
- Tufts University
- Imperial College London
- Abbott
- University of Florida
- University of Florence
- Merck
- University of Rochester
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- University of California, San Francisco
- Tuscaloosa Research & Education Advancement Corporation (TREAC)
- Horizon Therapeutics, LLC
- Melbourne Health
- Medical College of Wisconsin
- Flinders University
- University of Goettingen
- Manhattan Psychiatric Center
- Indiana University
- State University of New York
- University of Vienna
- Seoul National University
- American Psychiatric Association
- Bio Products Laboratory
- Hoosier Cancer Research Network
- +249 more
Organization Involved with Phase 3 Indications (159)
- Wayne State University
- Sumitomo Dainippon
- Angelini
- EndoCeutics Inc.
- Shijiazhuang Pharma Group (CSPC)
- Impax Laboratories
- The Canadian College of Naturopathic Medicine
- Biohaven Pharmaceuticals Inc.
- BC Centre on Substance Use
- Government of Canada
- Johanne and Einar Eilertsen's research fund
- Medistat Ltd., Israel
- Huddinge Hospital, Stockholm
- Alexion
- Federal University of Ceara
- Tangent Data
- National Institute of Mental Health and Neuro Sciences, India
- Sanofi
- St Tydfil's Hospital
- ZNA Antwerpen
- Asha Hospital, Hyderabad, India
- Inje University
- Shionogi
- Meridien Research
- UMC Utrecht
- Reinier van Arkel Group
- Maryland Center for Sexual Health
- Pritzker Family Foundation
- Jina Pharmaceuticals, Inc.
- Axsome Therapeutics, Inc.
- +129 more
Organization Involved with Phase 2 Indications (198)
- Temple University
- Consortium to Alleviate PTSD
- Theravance
- Synergy Research
- Wake Forest University
- Neumora Therapeutics, Inc.
- Magenta Therapeutics
- Instituto de Información e Investigación en Salud Mental A. C.
- International Obsessive-Compulsive Disorder Foundation
- Genentech
- Russian Academy of Medical Sciences
- Comprehensive Psychiatric Care, Norwich CT
- The Florey Institute of Neuroscience and Mental Health
- Northbrooke Research Center
- University of Alberta
- Ono Pharmaceuticals
- Alza
- University Clermont Auvergne
- University of California, Davis
- University of Lyon
- Finch Research and Development LLC.
- The Lymphoma Academic Research Organisation
- Pacific Neuroscience Institute
- Promethera Biosciences
- Hurd,Yasmin, Ph.D.
- Government of Korea
- HemaQuest Pharmaceuticals
- Elan Pharmaceuticals
- University of Southern Mississippi
- Kuhnil Pharmaceutical Co., Ltd.
- +168 more
Organization Involved with Phase 1 Indications (63)
- Algorithme Pharma Inc
- University of Basel
- BASi Clinical Research Unit
- National Network of Depression Centers
- Southern California Center for Sexual Health and Survivorship Medicine
- Semper Fi Fund
- University of Ottawa
- Patterson Trust Awards Program in Clinical Research
- Wuhan Psychiatric Hospital
- YRG Care
- Voyager Therapeutics
- County of Stockholm
- Pharmaceutical Research Unit, Jordan
- Institut Hospital del Mar d'Investigacions Mèdiques
- Waterloo Foundation
- Universidad Carlos III Madrid
- Karolinska Institute
- PPD
- OpenBiome
- University of Guelph
- Abdi Ibrahim Pharmaceuticals
- Shenzhen Geno-Immune Medical Institute
- CEDRA Clinical Research
- Trinity College Dublin
- iNova
- Coalition to Support America's Heroes
- Heffter Research Institute
- Cures Within Reach
- Tibotec
- Gateway Medical Research
- +33 more
Organization Involved with Other Experimental Indications (71)
- East Tennessee State University
- Aix-University of Marseille
- Landstuhl Regional Medical Center
- National Institute on Aging (NIA)
- Sheppard Pratt Health System
- Upstate Carolina
- Semmelweis University
- University of Quebec
- Humber River Hospital
- Kwai Chung Hospital
- Atlanta Research and Education Foundation
- Instituto Brasileiro de Osteopatia
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Almond Board of California
- Elegant And Olive Health Clinic, Canada
- National Institute of Nursing Research (NINR)
- Verifomics LLC
- Siriraj Hospital
- Zucker Hillside Hospital
- Centre National d'Etudes Spatiales
- University of Salerno
- Johannes Gutenburg University
- European Commission
- University of Tuebingen
- German Institute of Human Nutrition
- University Hospital Brno
- Yonsei University
- National Institute of Dental and Craniofacial Research (NIDCR)
- Jamaica Hospital Medical Center
- University of Bath
- +41 more